Cloning and Expression of Recombinant Human Interleukin 1 Receptor Antagonist in Escherichia Coli Strains, BL21 (DE3), Rosetta (DE3), and Origami (DE3)

Background: Recombinant human interleukin-1 receptor antagonist (IL-1RA) is a protein with 153 amino acids and molecular weight of 16.83 kDa. This drug protein is known as Anakinra, and has an effective application in the treatment of rheumatoid arthritis. This study was conducted to examine the pro...

Full description

Bibliographic Details
Published in:	مجله دانشکده پزشکی اصفهان
Main Authors:	Hanieh Fardgoli, Seyed Nezameddin Hoseini, Setareh Haghighat
Format:	Article
Language:	Persian
Published:	Isfahan University of Medical Sciences 2019-11-01
Subjects:	interleukin 1 receptor antagonist protein recombination escherichia coli
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/12229

Similar Items

Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain
by: Adrià López-Cano, et al.
Published: (2022-05-01)

Cloning and Expression of EBI3 and p28 Subunits of Human Interleukin 27 in E. coli
by: Ameneh Koochaki, et al.
Published: (2015-07-01)

CLONING AND EXPRESSION OF DNAK GENE ISOLATED FROM LOCAL ISOLATE OF E. COLI RU-3 IN BL21 CELL
by: Rihab H. Zghair, et al.
Published: (2025-06-01)

Engineering a recombination-resistant live attenuated vaccine candidate with suppressed interferon antagonists for PEDV
by: Mingde Liu, et al.
Published: (2025-07-01)

Cloning and expression of recombinant endo 1,4 β xylanase in origami strain and evaluation of microbial enzyme supplementation effects on broiler performance
by: Amin Sadeghi Alikelayeh, et al.
Published: (2021-12-01)

De novo enzyme design using Rosetta3.
by: Florian Richter, et al.
Published: (2011-01-01)

Efficacy of 5-HT3 receptor antagonists (ondansetron) vs dopamine receptor antagonists (droperidol) for preventing postoperative nausea, vomiting and headache: a meta-analysis
by: Chen Xiaoyun, et al.
Published: (2019-07-01)

Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
by: Amar Ramachandran, et al.
Published: (2014-01-01)

Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome
by: Hazem H. Ahmed, et al.
Published: (2022-01-01)

Serum interleukin-6, interleukin-8, and interleukin-1 receptor antagonist levels in South Indian fibromyalgia patients and its correlation with disease severity
by: Sandeep Surendran, et al.
Published: (2021-01-01)

Antagonistic activity of the native strain of Pseudomonas chlororaphis 3 of the Belgorod region against the bacterium of the genus Ralstonia
by: Avakova Alina, et al.
Published: (2021-01-01)

Modeling symmetric macromolecular structures in Rosetta3.
by: Frank DiMaio, et al.
Published: (2011-01-01)

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell
by: Ma J, et al.
Published: (2017-10-01)

Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases
by: Samuele Maramai, et al.
Published: (2016-10-01)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
by: Yu-Ching Fan, et al.
Published: (2020-12-01)

Intellectual Capital and Chaos of Innovation: Antagonist Coalition in Organizations
by: Asiye Yüksel
Published: (2023-06-01)

Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice
by: Salim M. A. Bastaki, et al.
Published: (2019-09-01)

Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3
by: Jialin Song, et al.
Published: (2025-07-01)

Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H3R antagonists
by: Jian Xin, et al.
Published: (2018-01-01)

Non-vitamin K oral antagonist (NOAC) compared to vitamin K antagonist (VKA) in left ventricular thrombus
by: Fahmi Al-Kaf, et al.
Published: (2024-06-01)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
by: Alireza Komaki, et al.
Published: (2014-07-01)

The Application of Adaptive Model Predictive Control for Fed-Batch <i>Escherichia coli</i> BL21 (DE3) Cultivation and Biosynthesis of Recombinant Proteins
by: Konstantins Dubencovs, et al.
Published: (2023-12-01)

Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis
by: Daichi Watanabe, et al.
Published: (2024-07-01)

Content of C-reactive protein, interleukin-1, interleukin-6 and interleukin-1 receptor antagonist in the blood of patients with early osteoarthrosis of the knee joints
by: M S Svetlova, et al.
Published: (2009-06-01)

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors
by: Alejandro Diaz-Barreiro, et al.
Published: (2025-01-01)

A novel mutation of interleukin-1 receptor antagonist (IL1RN) in a DIRA patient from Turkey: Diagnosis and treatment
by: Betül Sözeri, et al.
Published: (2018-10-01)

Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
by: Nermin Eissa, et al.
Published: (2022-07-01)

Association of Interleukin-1 Antagonist Receptor Gene Polymorphism (rs2236663) and Type 2 Diabetes in Gonabad city
by: Amir Najafi, et al.
Published: (2024-07-01)

Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
by: Victoria Harwell, et al.
Published: (2020-09-01)

Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01)

Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01)

Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation
by: Patrick Grudzien, et al.
Published: (2023-07-01)

Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF Antagonists
by: Khaled Draghmeh, et al.
Published: (2025-04-01)

Recombination Analysis of Non-Poliovirus Members of the Enterovirus C Species: Restriction of Recombination Events to Members of the Same 3DPol Cluster
by: Lieke Brouwer, et al.
Published: (2020-06-01)

Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease
by: Fangkun Yang, et al.
Published: (2023-10-01)

Neuroprotection, excitotoxicicity and nmda antagonists
by: RUBENS JOSÉ GAGLIARDI
Published: (2000-06-01)

CRF1 receptor antagonists in congenital adrenal hyperplasia: A systematic review and meta-analysis of phase 2 open-label and phase 3 clinical trials
by: Mir wajid Majeed, et al.
Published: (2025-06-01)

Robustification of RosettaAntibody and Rosetta SnugDock.
by: Jeliazko R Jeliazkov, et al.
Published: (2021-01-01)

Optimasi Kodon dan Konstruksi Plasmid Rekombinan Protein RBD SARS-CoV-2 pada E. coli BL21(DE3)
by: Elly Widyarni Eka Purnamasari, et al.
Published: (2024-01-01)

Natural bradykinin antagonists
by: João B. Calixto, et al.
Published: (1991-01-01)